On February 26, 2025, AIM ImmunoTech Inc. announced the appointment of David I. Chemerow to its Board of Directors, effective February 24, 2025, and also adopted Restated and Amended Bylaws reducing the quorum for stockholder meetings from 40% to 33.33%.